K Tsung
Overview
Explore the profile of K Tsung including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
29
Citations
573
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Norton A, Peplinski G, Tsung K
Ann Surg
. 1996 Oct;
224(4):555-60; discussion 560-2.
PMID: 8857859
Objective: The purpose of this study was to develop a noncytopathic vector for transient delivery of biologically active platelet-derived growth factor (PDGF) to wounds. Background: Topical application of the protein...
12.
Meko J, Tsung K, Norton J
Surgery
. 1996 Aug;
120(2):274-82; discussion 282-3.
PMID: 8751593
Background: Cancer gene therapy with interleukin-12 (IL-12) has generated much interest because of the potent antitumor effects of this cytokine. The purpose of this study was to construct a nonreplicating,...
13.
Doherty G, Tsung K, McCluskey B, Norton J
J Surg Res
. 1996 Jul;
64(1):68-74.
PMID: 8806476
Background: Recent evidence implicates endogenous interferon-gamma (IFN-gamma) in the host response to an immunogenic tumor (MCA105); antibody blockade of host IFN-gamma increased tumor growth rate (Doherty et al., Ann. Surg....
14.
Peplinski G, Tsung K, Meko J, Norton J
Ann Surg Oncol
. 1996 Jan;
3(1):15-23.
PMID: 8770297
Background: Cancer gene therapy expressing specific levels of multiple genes has not been adequately tested. This study investigates the antitumor effects of recombinant vaccinia viruses (recVVs) that express predictable levels...
15.
Tsung K, Yim J, Marti W, Buller R, Norton J
J Virol
. 1996 Jan;
70(1):165-71.
PMID: 8523521
Induction of the cytopathic effect (CPE) in cells infected with poxvirus seems ubiquitous in that it has been associated with all different strains and preparations of poxviruses, regardless of the...
16.
Meko J, Yim J, Tsung K, Norton J
Cancer Res
. 1995 Nov;
55(21):4765-70.
PMID: 7585501
We have constructed a recombinant vaccinia virus (recVV), vKT0334 mIL-12, containing the genes encoding the p35 and p40 subunits of murine interleukin-12 (mIL-12). In vitro experiments demonstrated that vKT0334 mIL-12...
17.
Peplinski G, Tsung K, Meko J, Norton J
Surgery
. 1995 Aug;
118(2):185-90; discussion 190-1.
PMID: 7638732
Background: Recombinant vaccinia virus (VV) encoding human interleukin-1 beta (vMJ601hIL-1 beta) given intravenously persists in tumor tissue and expresses hIL-1 beta for at least 9 days after treatment and is...
18.
19.
Bronte V, Tsung K, Rao J, Chen P, Wang M, Rosenberg S, et al.
J Immunol
. 1995 May;
154(10):5282-92.
PMID: 7730632
Neoplastic cells are generally poor immunogens. Transfection of the murine tumor CT-26 with beta-galactosidase (beta-gal), a protein from Escherichia coli, did not alter its growth rate in vivo, or its...
20.
Parenteau G, Doherty G, Peplinski G, Tsung K, Norton J
Ann Surg
. 1995 May;
221(5):572-7; discussion 577-8.
PMID: 7748039
Objective: The hypothesis is that systemic administration of recombinant tumor necrosis factor-alpha (TNF-alpha) and/or recombinant interleukin-1 alpha (IL-1 alpha) can decrease the rejection of a skin allograft. Summary Background Data:...